Prediction of asthma exacerbations in children by FeNO and non-invasive inflammatory markers in exhaled breath condensate

C. Robroeks, R. Jobsis, R. Braekers, H. Hendriks, E. Dompeling (Maastricht, Netherlands; Diepenbeek, Belgium)

Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children
Disease area: Airway diseases, Paediatric lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Robroeks, R. Jobsis, R. Braekers, H. Hendriks, E. Dompeling (Maastricht, Netherlands; Diepenbeek, Belgium). Prediction of asthma exacerbations in children by FeNO and non-invasive inflammatory markers in exhaled breath condensate. Eur Respir J 2008; 32: Suppl. 52, 3924

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prediction of CF exacerbations by FeNO and non-invasive inflammatory markers in exhaled breath condensate
Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation
Year: 2008


The biomarkers of atopy in exhaled breath condensate in patients with bronchial asthma
Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases
Year: 2010

Cystenil-leukotrienes as markers of airway inflammation in exhaled breath condensate of asthmatic children
Source: Eur Respir J 2002; 20: Suppl. 38, 412s
Year: 2002

Exhaled breath condensate for evaluation of inflammation in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 35s
Year: 2006

Cytokines in exhaled breath condensate of patients with asthma
Source: Annual Congress 2008 - Inflammatory biomarkers
Year: 2008

Assessment of exhaled breath condensate pH in asthma and COPD patients with exacerbation
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010

Inflammatory markers in exhaled breath condensate of two COPD phenotypes
Source: Eur Respir J 2005; 26: Suppl. 49, 260s
Year: 2005

Markers of airway diseases in exhaled breath condensate and their clinical value
Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases
Year: 2013


Exhaled breath condensate eicosanoids as markers of asthma severity
Source: Annual Congress 2008 - Understanding the mechanisms and the impact of severe asthma
Year: 2008


Leukotrienes in exhaled breath condensate in childhood asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 398s
Year: 2003

Leukotrienes in exhaled breath condensate of children with asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 39s
Year: 2001

Changes in exhaled breath condensate in asthma and COPD: A full analysis of mass-spectra
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010


Exhaled breath condensate biomarkers in COPD
Source: Eur Respir J 2008; 32: 472-486
Year: 2008



8-isoprostane and cys-leukotrienes in exhaled breath condensate (EBC) of children with asthma exacerbation
Source: Eur Respir J 2002; 20: Suppl. 38, 142s
Year: 2002

Exhaled breath condensate analysis in diagnostics of occupational asthma and rhinitis
Source: Eur Respir J 2006; 28: Suppl. 50, 619s
Year: 2006